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SYNOPSIS 
Individuals from disadvantaged communities are among millions of uninsured Americans 
gaining insurance under the Affordable Care Act. We examine whether health insurance and 
better access to care can mitigate the effects of the social determinants of health on cancer care 
for the leading four causes of cancer deaths in the United States.  
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STRUCTURED ABSTRACT 
PURPOSE: Individuals from disadvantaged communities are among millions of uninsured 
Americans gaining insurance under the Affordable Care Act. The extent to which health 
insurance can mitigate the effects of the social determinants of health on cancer care is 
unknown. 
METHODS: We linked the Surveillance, Epidemiology, and End Results (SEER) registries to 
US-Census data to study patients diagnosed with the 4 leading causes of cancer deaths 
between 2007-2011. We developed a county-level social determinants score using 5 measures 
of wealth, education and employment. We stratified patients into quintiles, with the lowest 
quintile representing the most disadvantaged communities. Logistic regression and Cox 
proportional hazards models were used to estimate associations and cancer-specific survival. 
RESULTS: A total of 364,507 patients aged 18-64 years were identified (134,105 
breast,106,914 prostate, 62,606 lung. and 60,881 colorectal). Overall, patients from the most 
disadvantaged communities (median household income=$42,885; 22% below poverty level; 
17% college completion) were more likely to present with distant disease (Odds ratio [OR]=1.6; 
p<0.001) and less likely to receive cancer-directed surgery (OR=0.8; p<0.001) than the least 
disadvantaged communities (median income=$78,249; 9% below poverty; 42% college 
completion). The differences persisted across quintiles regardless of insurance status. The 
effect of having insurance on cancer-specific survival was more pronounced in disadvantaged 
communities (40% vs. 31% relative benefit at 3 years). However, it did not fully mitigate the 
effect of social determinants on mortality (Hazard Ratio 0.77 vs. 0.68; p<0.001). 
CONCLUSIONS: Cancer patients from disadvantaged communities benefit most from health 
insurance and there is a reduction in disparities in outcome. However, the gap produced by 
social determinants of health cannot be bridged by insurance alone.  
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INTRODUCTION  
 Cancer is the second leading cause of death in the United States, and is responsible for 
one in every four deaths.1 Despite significant strides in overall cancer survival, several factors 
prevent many Americans from receiving optimal cancer care.2–6 Individuals without health 
insurance lack access to health care and are more likely to be diagnosed with cancer at a later 
stage and have worse outcomes.7,8 The Affordable Care Act (ACA) has aimed to expand access 
to care, largely through the Medicaid expansion, to individuals with incomes near the national 
poverty levels.9 In fact, it is estimated that Medicaid will cover 93 million individuals by 2024.10 
Thus, millions of individuals from disadvantaged communities and poor social determinants of 
health are among those gaining health insurance.  
However, it is unknown whether health insurance can mitigate the effects of the social 
determinants of health in patients from disadvantaged communities, and the complex interplay 
between these factors is not well understood. Social determinants of health are defined by the 
World Health Organization as the conditions in which people are born, live, learn, play, work and 
age.11 These community-level determinants, such as income inequality and high rates of 
unemployment, shape the disparities in access to health care,12 and are also associated with 
disproportionately lower cancer survival rates.13,14 How expanded insurance coverage will affect 
cancer care for Americans living in communities with varying social determinants has not been 
examined, and the effect of health insurance on cancer outcomes in varying social strata is 
unknown.4,8,15–17  
In this context, we use a contemporary and nationally-representative sample of non-
elderly adult patients, who are diagnosed with one of the four leading causes of cancer deaths, 
and explore the impact of health insurance on cancer care in different communities with varying 
social determinants of health. The results of this study help anticipate the effects of the ACA on 
cancer care and to what extent insurance mitigates the effects of the social determinants of 
health.   
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METHODS 
We conducted a retrospective cohort study using the Surveillance, Epidemiology, and 
End Results (SEER) database.18 The SEER database is the authoritative source for cancer 
incidence, survival, and prevalence, currently capturing 28% of the US population, and is 
representative of geographic, racial, and ethnic diversity. SEER collects demographic 
information (e.g., age, sex, and race/ ethnicity) and clinical information (e.g., primary tumor site, 
tumor histology, stage, treatment, and survival) from 18 cancer registries. Institutional Review 
Board approval is not required for publicly available data. 
Patient Population 
 Adult patients age 18-64 years, who were diagnosed with one of the 4 leading causes of 
cancer deaths (lung, female breast, prostate and colorectal), based on International 
Classification of Diseases for Oncology (ICD-O) site and histology codes between 1/2007 and 
12/2011 were included. Patients over age 65 were excluded since most are likely to be covered 
by Medicare. Patients for whom this was not their first and only malignancy were excluded. 
SEER started collecting patient-level insurance data in January 2007, and only released this 
information this past year.  
Main Exposure and Stratification Variables 
 Insurance status was the main exposure variable. Patients were categorized as 
uninsured, covered by Medicaid, and insured. The “Insured” category includes those with 
private insurance (managed care, health maintenance organization, or preferred-provider 
organization), Medicare, and coverage from the military or Veterans Affairs. Patients with 
unknown insurance status were excluded. 
We constructed a summary measure of the social determinants of health for each state-
county code using data on income (median household income; percentage of residents below 
the federal poverty level), education (percentage not completing high school; percentage 
finishing college), and occupation (percentage unemployed) from the 2008-2012 US Census 
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and then linked this information to the patient's state-county code of residence in the SEER data 
files. The summary measure was based on previously developed methods.19,20 In brief, a z-
score for each variable was estimated by subtracting the overall mean and dividing by the 
standard deviation (SD) for each county. Thus, a score of 2 for median household income in a 
county means that it is 2.0 SD above the mean. These z-scores were then summed for each of 
the five variables to obtain a summary measure of the social determinants. Summary scores 
ranged from  -21 to 10 with larger scores corresponding to a community with better social 
determinants. This score was used to group patients into quintiles of social determinants. The 
reliability (Cronbach’s alpha) of this summary score was 88.3%. 
Statistical Analyses 
In order to quantify the differences of health insurance on varying social strata, we 
conducted a stratified analysis. Analyses were stratified by quintiles of summary scores used to 
measure social determinants of health. Baseline patient characteristics across quintiles and 
insurance statuses were compared using logistic regression for categorical variables and one-
way analysis of variance for continuous variables with the Scheffe method.21 Unadjusted 
associations between the different insurance groups and cancer-specific survival were 
displayed using Kaplan-Meier curves and compared using the log-rank test within each social 
determinants quintile. 
A multivariable logistic regression model was used to determine the association between 
insurance status and receipt of cancer-directed surgery among patients with non-distant 
disease. The model adjusted for age, sex, race/ethnicity, marital status, cancer type, and stage. 
A multivariable Cox proportional hazards model, which adjusted for age, sex, race/ethnicity, 
cancer type, stage, and receipt of cancer-directed surgery was used to assess the effect of 
insurance on the endpoint of cancer-specific death for patients within each social determinants 
quintile. The adjusted odds ratios (aOR), adjusted hazards ratios (aHR), and their 95%CI’s are 
reported. 
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Due to the inherent limitation of interpreting hazard ratios between groups,22 and to 
facilitate the comparisons of the relative benefit of having health insurance across quintiles, a 
non-modeled measure was calculated by subtracting the difference of the probability of 3-year 
cancer-specific survival among those uninsured (i.e., control event-rate) from those insured (i.e., 
treated event-rate) and dividing it by the control event-rate. This relative benefit measure is akin 
to calculating relative risk reduction, and is easily estimated from the Kaplan-Meier curves. 
All statistical tests were two-sided and p-values<0.05 were considered significant. 
Statistical analyses were conducted using STATA special edition (version 13.1, StataCorp, 
College Station, TX).  
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RESULTS 
 A total of 364,507 patients between the ages of 18 and 64 years were diagnosed with 
one of the leading 4 causes of cancer deaths in the US between 1/2007 and 12/2011. 
Specifically, 134,105 (36.8%) had breast cancer, 106,914 (29.3%) had prostate cancer, 62,606 
(17.2%) had lung cancer, and 60,881 (16.7%) had colorectal cancer. Of the entire cohort, 
304,224 patients (83.5%) were insured, 43,572 (12%) had Medicaid coverage, and 16,711 
(4.6%) were uninsured. 
 The distributions of each of the county-level social determinants of health within each 
quintile are given in Table 1. For example, median household income increased in a linear 
fashion from $42,885 in the most disadvantaged quintile to $78,249 for the least disadvantaged 
quintile; adult residents completing college increased from 17.1% to 41.9%; and employment 
increased from 86.7% to 92.1% respectively. Of note, poverty rates and median household 
incomes in the middle quintile are similar to national averages from the US census bureau for 
the year 2011.23 The geographic distribution of the social determinant quintiles within SEER 
regions is shown in Figure 1. 
 The patient characteristics in the most disadvantaged and least disadvantaged 
communities are described in Table 2. Notably, patients in the most disadvantaged quintile 
were twice as likely to be uninsured (6.0% vs. 3.0%; p<0.001) and three-times as likely to be 
covered by Medicaid than those in the least disadvantaged communities (17.5% vs. 6.7%; 
p<0.001). The average age across insurance statuses and quintiles was clinically similar to the 
overall cohort (54.4 ±7.7 years). Of note, Medicaid coverage across all quintiles was 
predominantly comprised of females and unmarried individuals.  
Across all quintiles, lung cancer was the most common cancer among those uninsured, 
while breast cancer was the most common for those covered by Medicaid or those insured. 
Uninsured patients and those covered by Medicaid were more likely to present with distant 
disease than insured patients across all cancers. This effect was present within all social 
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determinant quintiles. In addition, the effect of the social determinants is apparent, as insured 
patients from the most disadvantaged communities were still more likely to present with distant 
disease than insured patients from the least disadvantaged communities (17.5% vs. 13.3%; 
p<0.001).  
 As shown in Figure 2, patients from the most disadvantaged communities have poor 
survival if uninsured and their cancer-specific survival markedly improves with insurance 
(p<0.001). Medicaid insurance is associated with a modest survival benefit for patients from 
disadvantaged communities (p<0.001), compared to the uninsured group, but its effect in 
patients from the least disadvantaged communities was negligible (p=0.19; Figure 2). Despite 
being insured, patients from the most disadvantaged quintiles still had lower cancer-specific 
survival when compared to insured patients from the least disadvantaged quintiles. However, 
the relative benefit of having insurance compared to being uninsured is more pronounced in 
patients from the most disadvantaged communities (40% vs. 31%) compared to those from the 
least disadvantaged communities. 
 Table 3 shows the adjusted effects of insurance on receipt of cancer-directed surgery 
and cancer-specific survival. First, health insurance is associated with higher rates of cancer-
directed surgery for patients with non-distant disease and improves cancer-specific survival 
across all communities. Despite having health insurance, adjusting for other covariates, and 
considering the baseline rates, patients from the most disadvantaged communities were still 
less likely to receive cancer-directed surgery (aOR=1.68 vs. 1.86) and had lower cancer-specific 
survival (aHR=0.75 vs. 0.68) than insured patients from the least disadvantaged communities. 
 To assess the robustness of the findings, we conducted a sensitivity analysis by each 
cancer type. We excluded patients with distant disease. Using a Weibull survival model, we saw 
insured patients from less disadvantaged communities had better cancer-specific survival than 
insured patients from the most disadvantaged across all cancer types.  
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DISCUSSION 
 In this nationally representative study of patients diagnosed with one of the four leading 
causes of cancer deaths we sought to examine the association between having health 
insurance and cancer survival, for patients living in communities with varying social 
determinants of health. We found a consistent relationship between a community’s relative 
advantage, measured by social determinants of health, and cancer care and outcomes, as 
measured by receipt of cancer-directed surgery and cancer-specific survival. Although health 
insurance appeared to mitigate this relationship, it did not fully abrogate the differences caused 
by the social determinants of health. Importantly, patients from disadvantaged communities had 
a larger relative benefit from health insurance, demonstrating their substantial need for 
improved access to care. Finally, Medicaid insurance was associated with a modest benefit on 
cancer survival for patients living in disadvantaged communities (compared to being uninsured), 
but did not have an appreciable effect in more advantaged communities.  
While previous studies had shown the disparities in cancer outcomes and processes of 
care,7,24 to the best of our knowledge, this is the first national study to explore the interplay 
between health insurance and social determinants of health, and the impact on cancer care and 
outcomes. The findings presented herein highlight the inequities in the structure of the 
healthcare system in the United States and have several implications. The intent of the ACA 
was to provide broader coverage and better access to care for millions of Americans who are 
largely from socially disadvantaged communities. While this is a steppingstone in crossing the 
quality chasm,25 our results demonstrate that providing better access to care alone is not 
sufficient for equitable cancer care. 
Although health insurance improved cancer care and survival across all communities, 
community-level social determinants significantly impacted its effectiveness. Insured patients 
from less disadvantaged communities still had higher odds of receiving cancer-directed surgery 
and better cancer-specific survival than insured patients from disadvantaged communities. This 
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differential access despite health insurance is compounded by the baseline disparities between 
the communities.  
The mechanisms underlying the persistent gap in cancer care and survival despite 
health insurance are unclear but probably multifactorial. Several studies have shown that 
patients from disadvantaged communities and minority groups may develop cancers with more 
aggressive biology or present with advanced disease.26,27 Other patient-related factors, 
including advanced age, differences in comorbid conditions,28 obesity,29 and health behaviors, 
such as smoking, may also influence receipt of therapy and survival.8 It is also plausible that 
less disadvantaged communities have better hospitals that in turn provide better care. Although 
not specific to cancer outcomes, Birkmeyer and colleagues20 had previously shown that 
disparities in surgical mortality were largely attributed to differences in the hospitals where 
patients received their care. This was the case for lung resection and colectomy, two 
procedures commonly performed for cancer. Other factors may stem directly from the public 
infrastructure (e.g., transportation) or the lack of social support, thereby causing a differential 
ability to interact with the healthcare system.  
Furthermore, the increased resources in less disadvantaged communities may allow 
patients to absorb indirect and additional uncovered costs. These costs are particularly 
burdensome for cancer patients, as they have higher out-of-pocket burdens than other 
chronically ill patients to begin with.30 Further, patients in less disadvantaged communities might 
have “better” insurance plans with lower deductibles and out-of-pocket maximums by virtue of 
their employment benefit package, as not all insurance plans are equal. In a population-based 
study, Shankaran and colleagues31 found that a significant proportion of colon cancer patients 
undergoing adjuvant therapy experienced financial hardship despite a large proportion of 
patients having health insurance. In their study, 40% of patients had to sell or refinance their 
home, borrowed money, or experienced >20% decline in annual income. As insurance plans 
increase deductibles, copayments or coinsurance fees, one can easily appreciate the prohibitive 
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effect this may have on cancer care in communities with poor social determinants. The financial 
toxicity of cancer should be taken into consideration by cost-sharing plans as more individuals 
from “financially frail” communities acquire health insurance.32  
In anticipating the downstream impact of the ACA, an interesting finding is that Medicaid 
provided a modest benefit on cancer care in disadvantaged communities, but not in less 
disadvantaged ones. This highlights the critical need for access to healthcare in disadvantaged 
communities, and provides evidence that providing Medicaid to patients in poor communities 
may save lives.  Since we are unable to assess the timing of Medicaid coverage relative to 
cancer diagnosis, the effect of having regular healthcare on when cancer is diagnosed is 
unknown. It is possible that those in more disadvantaged communities did not have coverage 
until the time of diagnosis whereas those in less disadvantaged communities had the benefit of 
more routine healthcare antecedent to a cancer diagnosis.33 However, these findings may also 
suggest that Medicaid, at least in its pre-ACA form, is not sufficient. In fact, patients with 
Medicaid had equivalent survival to uninsured patients, in less disadvantaged communities. This 
may be explained by the fact that Medicaid reimburses at lower levels and is not uniformly 
accepted by many health care providers and institutions,2 which may be particularly true in more 
“affluent” hospitals. This finding may also shed light on why the published literature on the 
impact of Medicaid on cancer care presents mixed results.7 It may also be the case that 
healthcare institutions in more affluent communities provide more effective charity care to 
uninsured patients.   
The realization that population health is in large part determined by the characteristics of 
the community in which they live as well as the clinical care they receive has driven many 
payers, hospitals and health systems to invest in stronger social support systems for their 
patients. However, addressing the social determinants of health and the gaps produced by them 
requires a coordinated effort that goes beyond the capabilities of the healthcare system alone. 
Rather, the pursuit of equitable cancer care should involve a multi-faceted approach including 
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concerted efforts that stretch across public and private sectors and government agencies.34 
Providing health insurance to the poor is an essential first step, but disadvantaged communities 
also require partnerships between healthcare facilities, community organizations and public 
health agencies.35 For example, other authors have shown that both Medicaid and uninsured 
patients are much more likely to present with advanced cancer,7 which further indicates that 
community-based cancer screening promotion might be a logical strategy in disadvantaged 
communities.  
By intent, the social determinants summary score is based on area-level data and not 
patient-level socioeconomic status. The distinction between the two is important. Social 
determinants are shaped by the distribution of resources at the area level, and can be the target 
for community interventions. While it would have been ideal to assess both the community’s 
determinants and an individual’s socioeconomic status, the latter are not reported in SEER, and 
each has its strengths and weaknesses. For example, patient-level measures of educational 
attainment are erroneous in young adults because their education may not yet be complete. 
Similarly, area-level measures may misclassify patients on both ends of the spectrum, although 
this reportedly occurs at random.36 The strength of area-based measures is that they provide 
contextual information on the social factors that may influence cancer care for all residents of 
the community, which is consistent with the primary focus of this study. It is also important to 
acknowledge that measuring county-level social determinants blurs the reality of neighborhood-
level experiences and may miss factors that would be significant if measured at the census-
level. 
This study has several limitations. First, patient-level insurance status in SEER is a 
broad classification. Nuances of covered services are unknown and the timing of insurance 
coverage relative to time of cancer diagnosis is unknown. Further, some uninsured patients who 
are diagnosed with cancer are enrolled in Medicaid either soon thereafter or at some point just 
prior to treatment and this is not clearly reported in the Primary Payer variable that SEER 
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collects which is defined as “primary payer/insurance carrier at the time of initial diagnosis 
and/or treatment”. Second, non-elderly patients who are insured with Medicare might have a 
higher proportion of disabled individuals, which may bias the results in the disadvantaged 
community. In addition, excluding patients >65 years of age may affect the external validity of 
the results on all cancer patients; however, the age group included in the study is the most 
affected by the ACA and Medicaid expansion. Further, SEER does not include data on patient 
functional status nor chemotherapy, which are important confounders and may proportionately 
differ according to social determinants. 
Another important limitation in this and other studies measuring the social determinants 
of health, is the fact that the currently used indices for social determinants are derived using a 
deprivation perspective rather than a strength-based approach. Ideally, measuring adverse 
social determinants should be accompanied by identifying the strengths and assets of 
communities. A focus on community assets, opportunities and resiliencies within the build and 
structure of the social environment within communities would be an additional resource for 
health promotion. This asset-based community development (ABCD) approach is still relatively 
new to researchers and policy makers, but may facilitate unique interventions at the community 
level. 
The intersection of race, poverty, and health is complex. It is evident that the most 
disadvantaged communities were comprised of more individuals from non-white races and 
ethnicities. Given the previously established racial-ethnic disparities in cancer outcomes, the 
associations between black race and various other indices of socioeconomic disadvantage, and 
the historic trust issues related to how black communities have interacted with cutting-edge 
cancer centers, these factors may have had an effect on the impact of health insurance in these 
communities. While we controlled for race/ethnicity in our models in hopes to mitigate these 
effects, a more in depth examination of this specific exposure goes beyond the scope of this 
paper. 
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In conclusion, cancer patients who are from disadvantaged communities benefit most 
from health insurance, thereby decreasing disparities in access to care and outcomes. 
However, the disparities gap produced by the social determinants of health cannot be bridged 
by insurance alone. As millions of Americans gain health insurance with the ACA, policy makers 
and payers need to keep in mind that providing healthcare insurance is necessary but not 
sufficient to eliminate inequities in cancer care, and substantial community-level efforts must be 
considered. Significant reform is needed for Medicaid to be successful in the post-ACA era. 
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LEGEND 
FIGURE 1: Map of the United States showing the geographic distribution of the social 
determinants quintiles across communities within the 18 SEER regions. Darker colors 
correspond to communities with greater social disadvantage. 
 
FIGURE 2: Kaplan-Meier curves for cancer specific survival by insurance status for patients 
living in the most disadvantaged communities (A), compared to patients living in the least 
disadvantaged communities (B). Note that insured patients in A, have worse survival than 
insured patients in B. However, the relative survival benefit from health insurance at 3 years is 
greater for patients from disadvantaged communities compared to those less disadvantaged 
(40% vs. 31%).
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Most 
disadvantaged 2 Middle 4
Least 
disadvantaged
No. of patients 79,019 69,990 70,456 72,788 72,254
Mean summary score -6.1 -1.8 0.68 2.7 5.1
Wealth/Income
Median household income ($) $42,885 $53,008 $55,891 $67,301 $78,249
Persons below federal poverty level (%) 21.9% 16.9% 14.1% 11.6% 8.6%
Education
Adult residents who completed high school (%) 77.8% 80.2% 86.9% 87.9% 90.7%
Adult residents who completed college (%) 17.1% 26.8% 28.0% 34.8% 41.9%
Employment
Employed residents (%) 86.7% 89.1% 90.7% 90.9% 92.1%
Social Determinants Quintile
Area-level Social Determinants of Health
Table 1: Distribution of Social Determinants According to Summary Score Quintile
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Uninsured Medicaid Insured Uninsured Medicaid Insured
Patients, n (%) 4,709 (6.0%) 13,815 (17.5%) 60,495 (76.6%) 2,174 (3.0%) 4,808 (6.7%) 65,272 (90.3%)
Age
Mean, years ± SD 53.9 ± 7.7 53.1 ± 8.2 55.1 ± 7.3 54 ± 8.2 53.2 ± 8.2 54.2 ± 7.7
Gender
Female 2,189 (46.5) 8,552 (61.9) 28,617 (47.3) 1,086 (50) 2,885 (60) 34,062 (52.2)
Marital Status
Married 1,935 (41.1) 4,757 (34.4) 39,699 (65.6) 825 (37.9) 1,470 (30.6) 45,419 (69.6)
Race and ethnicity
Non-hispanic white 2,754 (58.5) 7,103 (51.4) 39,948 (66) 1,348 (62) 2,466 (51.3) 48,116 (73.7)
Non-hispanic black 1,338 (28.4) 3,611 (26.1) 12,393 (20.5) 273 (12.6) 745 (15.5) 4,530 (6.9)
Hispanic 508 (10.8) 2,494 (18.1) 6,174 (10.2) 295 (13.6) 654 (13.6) 3,539 (5.4)
Other 109 (2.3) 607 (4.4) 1,980 (3.3) 258 (11.9) 943 (19.6) 9,087 (13.9)
Tumor Type
Lung 1,762 (37.4) 4,645 (33.6) 11,126 (18.4) 631 (29) 1,443 (30) 8,245 (12.6)
Colorectal 1,329 (28.2) 2,450 (17.7) 10,328 (17.1) 513 (23.6) 939 (19.5) 9,652 (14.8)
Breast 884 (18.8) 5,212 (37.7) 19,678 (32.5) 621 (28.6) 1,878 (39.1) 25,895 (39.7)
Prostate 734 (15.6) 1,508 (10.9) 19,363 (32) 409 (18.8) 548 (11.4) 21,480 (32.9)
Stage at presentation
Distant disease (Overall) 1,959 (41.6) 4,625 (33.5) 10,594 (17.5) 756 (34.8) 1,571 (32.7) 8,654 (13.3)
Distant disease (Lung) 1,268 (72) 2949 (63.5) 6552 (58.9) 440 (69.7) 936 (64.9) 4946 (60)
Distant disease (Colorectal) 442 (33.3) 766 (31.3) 2296 (22.2) 181 (35.3) 319 (34) 1998 (20.7)
Distant disease (Breast) 148 (16.7) 736 (14.1) 1280 (6.5) 92 (14.8) 243 (12.9) 1308 (5.1)
Distant disease (Prostate) 101 (13.8) 174 (11.5) 466 (2.4) 43 (10.5) 73 (13.3) 402 (1.9)
Cancer-directed surgery
Received* 1,894 (68.9) 6,831 (74.3) 38,387 (76.9) 993 (70) 2,526 (78) 45,937 (81.1)
*Excludes patients with distant disease
Most Disadvantaged Communites Least Disadvantaged Communities
Characteristics
Table 2: Patient Characteristics by Insurance Status in the Most and Least Disadvantaged Communities.
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Most 
disadavantaged Middle
Least 
disadvantaged
Uninsured
Medicaid 1.04 [0.91-1.18] 0.98 [0.84-1.15] 1.05 [0.86-1.28]
Insured 1.68 [1.50-1.89] 1.60 [1.40-1.84] 1.86 [1.58-2.19]
Uninsured
Medicaid 1.02 [0.96-1.09] 1.03 [0.95-1.11] 0.98 [0.88-1.09]
Insured 0.75 [0.71-0.79] 0.78 [0.74-0.85] 0.68 [0.62-0.75]
Cancer-specific mortality;                       
aHR [95% Confidence Interval]**
Reference
*Excludes patients with distant disease. (aOR: adjusted odds ratio, aHR: adjusted hazard ratio).
**Survival model adjusted for age, sex, race/ethnicity, marital status, cancer type, stage and 
receipt of cancer-directed surgery.
Table 3: Effect of Health Insurance on Cancer-Care Stratified by Social Determinants Quintile
Measures of Effect
Social Determinants Quintile
Receipt of cancer-directed surgery; 
aOR [95% Confidence Interval]*
Reference
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